Skip to main content
. 2023 Jul 21;7(18):5554–5565. doi: 10.1182/bloodadvances.2023009840

Table 2.

Multivariate analyses for DFS, OS, GRFS, and TRM

Variable DFS
HR 95% CI P
Previous autologous HSCT:
no/yes
1.69 0.4-7.17 .473
DRI:
High/very high vs intermediate/low
2.33 0.98-5.55 .056
Variable OS
HR 95% CI P
DRI:
High/very high vs intermediate/low
2.46 1.02-5.95 .046
Previous autologous HSCT:
yes/no
2.91 0.39-21.6 .296
Variable GRFS
HR 95% CI P
DRI:
High/very high vs intermediate/low
2.36 1.1-5.06 .028
Variable TRM
HR 95% CI P
MAC vs RIC 1.92 .197
CD3 dose infused:
Less than median vs greater than or equal to median
0.34 .063